Webinar "Treatment of COVID19 with Remdesivir under eIND1" - Dr. Ji Sun
UC San Diego Health Sciences International partnered with the Saudi Pharmaceutical Society and the Virtual Medical Academy to present a webinar on The Treatment of COVID-19 with Remdesivir under an eIND. Dr. Ji Sun, Director of UC San Diego’s Investigational Drug Service provided the participants with
- An overview the recent updates in the treatment / management of COVID-19
- A discussion the employing Remdesivir as a useful agent for COVID-19 therapy and
- Knowledge to help improve skills in the pharmacologic management of COVID-19
This webinar was attended by more than 3,000!
UC San Diego has been at the forefront during this recent pandemic and leading efforts in testing, vaccine development, treatment development and patient management.